It’s been a busy couple of weeks, and we’re taking this time to catch up on some specific biosimilar product news. Samsung Bioepis and Teva Launches Their Eculizumab Biosimilar The biosimilar maker Samsung Bioepis and its marketing partner Teva Pharmaceuticals announced on April 7 that it had launched Epysqli in the United States. This is … Continue reading Biosimilar Bytes: Eculizumab Biosimilar Launches, Rights to Actemra Biosimilar Sold, and New Biosimilar Bevacizumab Approved